MCKERRACHER LISA has a total of 17 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Canada, United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NOVARTIS INT PHARM LTD, HAWAII BIOTECH INC and PIERRE FABRE MEDICAMENT SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | United States | 5 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Machines | |
#6 | Measurement | |
#7 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Mckerracher Lisa | 17 |
#2 | Lehmann Maxime | 5 |
#3 | Lubell William D | 3 |
#4 | Thouin Eryk | 3 |
#5 | Munzer Jon S | 1 |
Publication | Filing date | Title |
---|---|---|
US2008233098A1 | RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth | |
US2007270340A1 | ADP-ribosyl transferase fusion variant proteins | |
CA2400996A1 | 1,4-substituted cyclohexane derivatives | |
CA2367636A1 | Fusion proteins | |
CA2342970A1 | Fusion proteins | |
CA2325842A1 | Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof | |
CA2325765A1 | Method for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof | |
CA2214841A1 | Rho antagonists and their use to block inhibition of neurite outgrowth |